Stelara Ustekinumab 45 Mg Injection - Origin: India

Key Features :-
Biologic treatment for autoimmune diseases.
Targets IL-12 and IL-23 cytokines to reduce inflammation.
Used for moderate to severe plaque psoriasis.
Treats Crohna s disease and ulcerative colitis.
Administered via subcutaneous injection.
Reduces symptoms of psoriatic arthritis.
Typically dosed every 12 weeks after initial loading.
Proven to improve skin clearance and reduce flare-ups.
Well-tolerated with a manageable side-effect profile.
Helps improve quality of life for chronic inflammatory conditions.
STELARA (ustekinumab) is a prescription biologic medication used to treat chronic inflammatory conditions caused by an overactive immune system. It works by blocking two specific proteins, IL-12 and IL-23, which are known to trigger inflammation in the body.